Skip to main content
. 2019 Aug 1;20(4):3103–3112. doi: 10.3892/mmr.2019.10548

Figure 6.

Figure 6.

KM plotter predicts a poorer prognosis for gastric cancer patients with high expression of COL12A1. (A) OS in all patients (n=631); (B) OS in male patients; and (C) OS in patients with lymph node metastasis. (D) PFS (n=522) in all patients; (E) PFS in male patients; and (F) PFS in patients with lymph node metastasis. OS, overall survival; PFS, progression-free survival; COL12A1, collagen type XII α1 chain.